The overall goal of this proposal is to investigate the added benefit of increased high-density cholesterol (HDL) serum levels on atherosclerotic plaque architecture and composition over and above those achieved by lipid lowering statin therapy, in older individuals with cardiovascular disease. With improved understanding of the basic mechanisms underlying lipid lowering therapy, as well as the development of technology to measure its beneficial effects on atherosclerosis, it has become possible to design smaller clinical trials that use surrogate endpoints to determine the efficacy of treatment strategies taylored to specific patient groups. This clinical trial will use state-of-the-art magnetic resonance imaging (MRI) technology sensitive enough to measure reduction of atherosclerotic plaque size as well as alterations of plaque composition directly in the aorta and carotid arteries. In addition, this study will further our understanding of reduced inflammation associated with lipid lowering therapy as potential mediators of plaque regression, determined by MRI as alterations of plaque architecture and composition. We will test the hypothesis that NCEP guided lipid lowering therapy combined with 20 percent or greater increase in serum HDL induced by long-acting niacin reduces plaque size in older individuals with cardiovascular disease. To test our hypothesis, we have the following specific aims: 1) to determine the effects of simvastatin vs. simvastatin augmented by niacin therapy on plaque size and composition, 2) to determine whether alterations of inflammatory markers of atherosclerosis induced by lipid lowering therapy parallel alterations of plaque architecture and composition in older patients with cardiovascular disease, 3) to determine the effects of these interventions on the incidence of cardiovascular and cerebrovascular events. The results of the proposed trial will be directly applicable to developing strategies for plaque stabilization in the elderly who suffer the most from the severe complications of advanced cardiovascular atherosclerosis. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG021570-02
Application #
6729155
Study Section
Special Emphasis Panel (ZRG1-CCVS (01))
Program Officer
Badinelli, Joanna
Project Start
2003-04-01
Project End
2007-02-28
Budget Start
2004-04-01
Budget End
2005-02-28
Support Year
2
Fiscal Year
2004
Total Cost
$564,823
Indirect Cost
Name
Johns Hopkins University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Sara, Leonardo; Rochitte, Carlos E; Lemos, Pedro A et al. (2014) Accuracy of multidetector computed tomography for detection of coronary artery stenosis in acute coronary syndrome compared with stable coronary disease: a CORE64 multicenter trial substudy. Int J Cardiol 177:385-91
Yan, Raymond T; Miller, Julie M; Rochitte, Carlos E et al. (2013) Predictors of inaccurate coronary arterial stenosis assessment by CT angiography. JACC Cardiovasc Imaging 6:963-72
Sibley, Christopher T; Vavere, Andrea L; Gottlieb, Ilan et al. (2013) MRI-measured regression of carotid atherosclerosis induced by statins with and without niacin in a randomised controlled trial: the NIA plaque study. Heart 99:1675-80
Arbab-Zadeh, Armin; Miller, Julie M; Rochitte, Carlos E et al. (2012) Diagnostic accuracy of computed tomography coronary angiography according to pre-test probability of coronary artery disease and severity of coronary arterial calcification. The CORE-64 (Coronary Artery Evaluation Using 64-Row Multidetector Computed Tomog J Am Coll Cardiol 59:379-87
Vavere, Andrea L; Arbab-Zadeh, Armin; Rochitte, Carlos E et al. (2011) Coronary artery stenoses: accuracy of 64-detector row CT angiography in segments with mild, moderate, or severe calcification--a subanalysis of the CORE-64 trial. Radiology 261:100-8
Gottlieb, Ilan; Miller, Julie M; Arbab-Zadeh, Armin et al. (2010) The absence of coronary calcification does not exclude obstructive coronary artery disease or the need for revascularization in patients referred for conventional coronary angiography. J Am Coll Cardiol 55:627-34
Wykrzykowska, Joanna J; Arbab-Zadeh, Armin; Godoy, Gustavo et al. (2010) Assessment of in-stent restenosis using 64-MDCT: analysis of the CORE-64 Multicenter International Trial. AJR Am J Roentgenol 194:85-92
Cheng, Susan; Fernandes, VerĂ´nica R S; Bluemke, David A et al. (2009) Age-related left ventricular remodeling and associated risk for cardiovascular outcomes: the Multi-Ethnic Study of Atherosclerosis. Circ Cardiovasc Imaging 2:191-8
Miller, Julie M; Dewey, Marc; Vavere, Andrea L et al. (2009) Coronary CT angiography using 64 detector rows: methods and design of the multi-centre trial CORE-64. Eur Radiol 19:816-28
Miller, Julie M; Rochitte, Carlos E; Dewey, Marc et al. (2008) Diagnostic performance of coronary angiography by 64-row CT. N Engl J Med 359:2324-36

Showing the most recent 10 out of 18 publications